[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Capecitabine.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Streptokinase is combined with Capecitabine.]
[J01GA01, streptomycin, Capecitabine may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Capecitabine.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Capecitabine.]
[L04AA27, fingolimod, Capecitabine may increase the immunosuppressive activities of Fingolimod.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01CG01, sulbactam, Capecitabine may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The metabolism of Capecitabine can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Capecitabine can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Capecitabine.]
[J01EC03, sulfamoxole, The metabolism of Capecitabine can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Capecitabine can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Capecitabine can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Capecitabine can be decreased when combined with Sulfisoxazole.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Capecitabine.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Capecitabine.]
[L02BA01, tamoxifen, The metabolism of Capecitabine can be decreased when combined with Tamoxifen.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Capecitabine can be decreased when combined with Teniposide.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Capecitabine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Capecitabine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Tetracaine.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A04AD10, dronabinol, The metabolism of Capecitabine can be decreased when combined with Dronabinol.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Thalidomide is combined with Capecitabine.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Capecitabine is combined with Eribulin.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Capecitabine is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Capecitabine.]
[G04BE06, moxisylyte, Capecitabine may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Capecitabine may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Capecitabine can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01AA12, tobramycin, Capecitabine may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Capecitabine.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Capecitabine.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N06AF04, tranylcypromine, The metabolism of Capecitabine can be decreased when combined with Tranylcypromine.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Capecitabine.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Capecitabine.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Capecitabine.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Capecitabine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Capecitabine.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Mometasone is combined with Capecitabine.]
[A03AA05, trimebutine, Capecitabine may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Capecitabine.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be decreased when combined with Capecitabine.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Capecitabine.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Capecitabine.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Belimumab.]
[L01FX04, ipilimumab, Capecitabine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Capecitabine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[J05AG05, rilpivirine, The metabolism of Capecitabine can be decreased when combined with Rilpivirine.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Capecitabine.]
[S01AA28, vancomycin, Capecitabine may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Capecitabine is combined with Belatacept.]
[N03AX21, ezogabine, Capecitabine may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Capecitabine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC24, ticagrelor, The metabolism of Capecitabine can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Capecitabine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, Capecitabine may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Vinblastine is combined with Capecitabine.]
[L01CA02, vincristine, The risk or severity of adverse effects can be increased when Vincristine is combined with Capecitabine.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Capecitabine.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Capecitabine.]
[B01AA03, warfarin, Warfarin may increase the anticoagulant activities of Capecitabine.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Capecitabine.]
[L01EC01, vemurafenib, The metabolism of Capecitabine can be decreased when combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Capecitabine is combined with Brentuximab vedotin.]
[M05BA05, tiludronic acid, Capecitabine may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Capecitabine may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Capecitabine.]
[R03DC01, zafirlukast, The metabolism of Capecitabine can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Capecitabine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Capecitabine may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Capecitabine.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Capecitabine.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Capecitabine.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Capecitabine.]
[J01DH04, doripenem, Capecitabine may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Capecitabine.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Capecitabine.]
[J02AC03, voriconazole, The metabolism of Capecitabine can be decreased when combined with Voriconazole.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Capecitabine.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Capecitabine is combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Capecitabine.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Azacitidine is combined with Capecitabine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Azathioprine is combined with Capecitabine.]
[L01BC05, gemcitabine, The serum concentration of Capecitabine can be increased when it is combined with Gemcitabine.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[G04BE10, avanafil, The metabolism of Avanafil can be decreased when combined with Capecitabine.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Capecitabine.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Capecitabine.]
[L01FD02, pertuzumab, The risk or severity of cardiotoxicity can be increased when Capecitabine is combined with Pertuzumab.]
[A08AA11, lorcaserin, Capecitabine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Capecitabine may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Carfilzomib.]
[L02BB04, enzalutamide, The metabolism of Capecitabine can be increased when combined with Enzalutamide.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Bosutinib.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Capecitabine is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Capecitabine.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Capecitabine is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Aldosterone.]
[L01EX05, regorafenib, The metabolism of Capecitabine can be decreased when combined with Regorafenib.]
[C01AA01, acetyldigitoxin, Acetyldigitoxin may decrease the cardiotoxic activities of Capecitabine.]
[D02BA02, octinoxate, Capecitabine may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Capecitabine can be increased when combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Bendamustine.]
[N04BD02, rasagiline, Capecitabine may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Capecitabine.]
[L04AA29, tofacitinib, Capecitabine may increase the immunosuppressive activities of Tofacitinib.]
[V09IX04, fluorodeoxyglucose F18, Capecitabine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Capecitabine.]
[G04BE03, sildenafil, The metabolism of Capecitabine can be decreased when combined with Sildenafil.]
[V08CA11, gadofosveset, Capecitabine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ponatinib.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Capecitabine.]
[A16AX08, teduglutide, Capecitabine may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Capecitabine may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Capecitabine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Capecitabine is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Capecitabine.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Capecitabine is combined with Dimethyl fumarate.]
[M04AB03, benzbromarone, The metabolism of Capecitabine can be decreased when combined with Benzbromarone.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Benzocaine.]
[L03AA12, ancestim, Capecitabine may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Capecitabine.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Capecitabine is combined with Everolimus.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01EC02, dabrafenib, The metabolism of Capecitabine can be decreased when combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01EE01, trametinib, Capecitabine may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Capecitabine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Capecitabine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[L03AA14, lipegfilgrastim, Capecitabine may increase the myelosuppressive activities of Lipegfilgrastim.]
[A10BJ03, lixisenatide, Capecitabine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Capecitabine may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ibrutinib.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Capecitabine.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J05AP08, sofosbuvir, Capecitabine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Capecitabine.]
[C01CA27, droxidopa, Capecitabine may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Capecitabine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, The metabolism of Capecitabine can be increased when combined with Apremilast.]
[L02BG02, formestane, Capecitabine may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The metabolism of Capecitabine can be increased when combined with Betamethasone.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Capecitabine.]
[V03AB34, fomepizole, Capecitabine may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[L04AC11, siltuximab, The metabolism of Capecitabine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Capecitabine can be decreased when combined with Ceritinib.]
[B01AC26, vorapaxar, The risk or severity of bleeding can be increased when Vorapaxar is combined with Capecitabine.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Vedolizumab.]
[B01AA07, acenocoumarol, Acenocoumarol may increase the anticoagulant activities of Capecitabine.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Capecitabine is combined with Belinostat.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Idelalisib.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Capecitabine.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Capecitabine is combined with Peginterferon beta-1a.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01XA05, oritavancin, The metabolism of Capecitabine can be decreased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Decitabine.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Pirfenidone.]
[S03AA06, gentamicin, Capecitabine may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Blinatumomab.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Olaparib.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Capecitabine.]
[B01AF03, edoxaban, Capecitabine may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[L04AC10, secukinumab, The metabolism of Capecitabine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Palbociclib.]
[L01XH03, panobinostat, The risk or severity of adverse effects can be increased when Capecitabine is combined with Panobinostat.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Capecitabine.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Capecitabine is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Capecitabine.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Capecitabine.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Capecitabine.]
[V03AB37, idarucizumab, Capecitabine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Capecitabine.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Capecitabine can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Capecitabine.]
[L01XG03, ixazomib, Capecitabine may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[A10BB31, acetohexamide, The metabolism of Acetohexamide can be decreased when combined with Capecitabine.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Capecitabine.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Capecitabine.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ixekizumab.]
[N05BA08, bromazepam, Capecitabine may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Capecitabine may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Bupivacaine.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Capecitabine.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Busulfan is combined with Capecitabine.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Capecitabine is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Capecitabine.]
[M02AA03, clofezone, Capecitabine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Capecitabine.]
[L01XK03, rucaparib, The metabolism of Capecitabine can be decreased when combined with Rucaparib.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Brodalumab.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AA36, ocrelizumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ocrelizumab.]
[A06AH05, naldemedine, Capecitabine may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Capecitabine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Capecitabine may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Capecitabine.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Capecitabine.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N07XX13, valbenazine, Capecitabine may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Capecitabine can be increased when combined with Infliximab.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Capecitabine can be increased when combined with Delafloxacin.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Capecitabine.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Guselkumab.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Antilymphocyte immunoglobulin (horse).]
[L01XX59, enasidenib, The metabolism of Capecitabine can be decreased when combined with Enasidenib.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Capecitabine is combined with Vorinostat.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Capecitabine can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Capecitabine.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Capecitabine.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Capecitabine.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Capecitabine is combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Capecitabine.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J05AX18, letermovir, The metabolism of Capecitabine can be increased when combined with Letermovir.]
[C01AA02, acetyldigoxins, Acetyldigoxin may decrease the cardiotoxic activities of Capecitabine.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Capecitabine may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[L02BB05, apalutamide, The metabolism of Capecitabine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Capecitabine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Capecitabine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Capecitabine.]
[N03AX24, cannabidiol, The metabolism of Capecitabine can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Capecitabine can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Baricitinib.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01GB14, plazomicin, Capecitabine may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[L01XX62, ivosidenib, The metabolism of Capecitabine can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, Capecitabine may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Capecitabine can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Capecitabine.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Capecitabine.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Capecitabine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Capecitabine.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AA39, emapalumab, The metabolism of Capecitabine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Capecitabine.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ravulizumab.]
[A06AX05, prucalopride, Capecitabine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Capecitabine.]
[B01AC23, cilostazol, The risk or severity of bleeding can be increased when Cilostazol is combined with Capecitabine.]
[P02BX04, triclabendazole, The metabolism of Capecitabine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Capecitabine.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Capecitabine is combined with Siponimod.]
[N06BA14, solriamfetol, Capecitabine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Capecitabine.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Capecitabine is combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Capecitabine can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Capecitabine can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Capecitabine is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Risankizumab.]
[L01EM03, alpelisib, The metabolism of Capecitabine can be increased when combined with Alpelisib.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Upadacitinib.]
[N07XX11, pitolisant, Capecitabine may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Capecitabine.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Capecitabine is combined with Deflazacort.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Capecitabine.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Capecitabine is combined with Diroximel fumarate.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Capecitabine.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Capecitabine.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[M09AX08, golodirsen, Capecitabine may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Capecitabine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01EX18, avapritinib, The metabolism of Capecitabine can be decreased when combined with Avapritinib.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Teprotumumab.]
[M01AX21, diacetylrhein, The metabolism of Capecitabine can be decreased when combined with Diacerein.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Capecitabine.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ozanimod.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Capecitabine.]
[R02AA03, dichlorobenzyl alcohol, Capecitabine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Capecitabine may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Capecitabine.]
[M01AH02, rofecoxib, The metabolism of Rofecoxib can be decreased when combined with Capecitabine.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Capecitabine.]
[C08CA16, clevidipine, The metabolism of Capecitabine can be decreased when combined with Clevidipine.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Capecitabine.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Capecitabine.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Capecitabine is combined with Fluprednidene.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[V08CA05, mangafodipir, Capecitabine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Capecitabine.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Capecitabine is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Dyclonine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Capecitabine is combined with Stepronin.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Capecitabine.]
[L04AC19, satralizumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Satralizumab.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01EX23, pralsetinib, The metabolism of Capecitabine can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Capecitabine.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02BA03, choline salicylate, Capecitabine may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Capecitabine.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A16AX20, lonafarnib, The metabolism of Lonafarnib can be decreased when combined with Capecitabine.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Fludarabine is combined with Capecitabine.]
[M01AX25, chondroitin sulfates, Capecitabine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Capecitabine is combined with Voclosporin.]
[L01EX21, tepotinib, The metabolism of Capecitabine can be decreased when combined with Tepotinib.]
[N03AX10, felbamate, The metabolism of Capecitabine can be decreased when combined with Felbamate.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Capecitabine.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Capecitabine.]
[N02BG07, flupirtine, Capecitabine may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Capecitabine.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ponesimod.]
[S01LA08, bevacizumab, The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Capecitabine.]
[L03AB10, peginterferon alfa-2b, The metabolism of Capecitabine can be increased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The serum concentration of the active metabolites of Capecitabine can be increased when Capecitabine is used in combination with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Capecitabine.]
[S03AA07, ciprofloxacin, Ciprofloxacin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Capecitabine.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Capecitabine is combined with Pegcetacoplan.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Capecitabine is combined with Belumosudil.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Anifrolumab.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Capecitabine.]
[A10BB12, glimepiride, The metabolism of Glimepiride can be decreased when combined with Capecitabine.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Capecitabine.]
[L01EA06, asciminib, The serum concentration of Capecitabine can be increased when it is combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Capecitabine.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Capecitabine.]
[B06AX04, mitapivat, The metabolism of Capecitabine can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Levobupivacaine.]
[N06AA04, clomipramine, Capecitabine may decrease the excretion rate of Clomipramine which could result in a higher serum level.]
[N03AE01, clonazepam, Clonazepam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C01EB24, mavacamten, The metabolism of Capecitabine can be increased when combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Deucravacitinib.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Capecitabine.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Capecitabine is combined with Clozapine.]
[J01GB12, arbekacin, Capecitabine may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Capecitabine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[M04AC01, colchicine, Capecitabine may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Capecitabine may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Capecitabine is combined with Leflunomide.]
[A04AA03, tropisetron, Capecitabine may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Capecitabine.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Nelarabine.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Indobufen is combined with Capecitabine.]
[J05AB14, valganciclovir, Capecitabine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Capecitabine may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Capecitabine may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Capecitabine may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Capecitabine may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Capecitabine may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The metabolism of Capecitabine can be decreased when combined with Valdecoxib.]
[C01AA06, lanatoside C, Lanatoside C may decrease the cardiotoxic activities of Capecitabine.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Capecitabine.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Capecitabine.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N05BA10, ketazolam, Capecitabine may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01EA01, imatinib, The metabolism of Capecitabine can be decreased when combined with Imatinib.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Capecitabine.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N07BC04, lofexidine, Capecitabine may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Capecitabine may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Capecitabine can be decreased when combined with Manidipine.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Meprednisone.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[R06AE03, cyclizine, The metabolism of Capecitabine can be decreased when combined with Cyclizine.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Capecitabine may decrease the excretion rate of Melperone which could result in a higher serum level.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Capecitabine.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Capecitabine.]
[S01XA18, cyclosporine, Capecitabine may increase the immunosuppressive activities of Cyclosporine.]
[N06BA07, modafinil, The metabolism of Capecitabine can be decreased when combined with Modafinil.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Capecitabine.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Cytarabine is combined with Capecitabine.]
[M01AH05, etoricoxib, The metabolism of Capecitabine can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Capecitabine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Dactinomycin is combined with Capecitabine.]
[J04BA02, dapsone, The metabolism of Capecitabine can be increased when combined with Dapsone.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Capecitabine.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Capecitabine.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Capecitabine.]
[N07BB05, nalmefene, Capecitabine may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N06AX06, nefazodone, Capecitabine may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Capecitabine may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, The metabolism of Capecitabine can be decreased when combined with Nilutamide.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Capecitabine.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N06AA01, desipramine, Capecitabine may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[C01AA07, deslanoside, Deslanoside may decrease the cardiotoxic activities of Capecitabine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Capecitabine.]
[V04CH02, indigo carmine, Capecitabine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Capecitabine.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Dexamethasone.]
[L04AB04, adalimumab, The metabolism of Capecitabine can be increased when combined with Adalimumab.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Capecitabine.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Capecitabine.]
[N06AB05, paroxetine, The metabolism of Capecitabine can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Capecitabine can be decreased when combined with Clopidogrel.]
[C01DA05, pentaerythritol tetranitrate, Capecitabine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Capecitabine may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Capecitabine.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Cinchocaine.]
[R05DA08, pholcodine, Capecitabine may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Capecitabine.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ixabepilone.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be increased when it is combined with Capecitabine.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Capecitabine is combined with Pirarubicin.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, The metabolism of Capecitabine can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Difluocortolone.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C01AA04, digitoxin, Digitoxin may decrease the cardiotoxic activities of Capecitabine.]
[C01AA05, digoxin, Capecitabine may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Capecitabine.]
[N02AA03, hydromorphone, The metabolism of Hydromorphone can be decreased when combined with Capecitabine.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Capecitabine.]
[J05AE08, atazanavir, The metabolism of Capecitabine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Treprostinil can be decreased when combined with Capecitabine.]
[H03BC01, potassium perchlorate, Capecitabine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Capecitabine.]
[V03AB09, dimercaprol, Capecitabine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Dimethyl sulfoxide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C05CA03, diosmin, The metabolism of Capecitabine can be decreased when combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Capecitabine.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Dipyridamole is combined with Capecitabine.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Capecitabine.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Sirolimus is combined with Capecitabine.]
[S01AX06, resorcinol, Capecitabine may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Natalizumab.]
[S02AA12, rifamycin SV, The metabolism of Capecitabine can be decreased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Capecitabine can be increased when combined with Rifapentine.]
[R06AE09, levocetirizine, Capecitabine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Capecitabine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Ropivacaine.]
[L01EX01, sunitinib, The risk or severity of QTc prolongation can be increased when Capecitabine is combined with Sunitinib.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Capecitabine.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01BC05, ketorolac, The metabolism of Ketorolac can be decreased when combined with Capecitabine.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Capecitabine.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Doxorubicin is combined with Capecitabine.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N06AB06, sertraline, The metabolism of Capecitabine can be decreased when combined with Sertraline.]
[A08AA10, sibutramine, Capecitabine may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, The metabolism of Capecitabine can be decreased when combined with Simvastatin.]
[A12CA02, sodium sulfate, Capecitabine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Capecitabine is combined with Corticotropin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Temozolomide is combined with Capecitabine.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Capecitabine.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Capecitabine.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N06AG03, toloxatone, Capecitabine may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C03CA04, torsemide, The metabolism of Capecitabine can be decreased when combined with Torasemide.]
[N05CC01, chloral hydrate, Capecitabine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Capecitabine.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Capecitabine is combined with Trilostane.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Capecitabine is combined with Trofosfamide.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Capecitabine.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Capecitabine.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01EA01, epinephrine, The metabolism of Capecitabine can be decreased when combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Capecitabine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Capecitabine.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Capecitabine.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Capecitabine.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Carboplatin is combined with Capecitabine.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[B01AC11, iloprost, The risk or severity of bleeding can be increased when Iloprost is combined with Capecitabine.]
[L03AX05, pidotimod, Capecitabine may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Capecitabine may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Capecitabine.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Estramustine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J04AK02, ethambutol, The metabolism of Capecitabine can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Capecitabine is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Capecitabine can be decreased when combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Capecitabine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01CB01, etoposide, The risk or severity of adverse effects can be increased when Etoposide is combined with Capecitabine.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Capecitabine.]
[P01AX07, trimetrexate, Capecitabine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Capecitabine.]
[N06AB08, fluvoxamine, The metabolism of Capecitabine can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Capecitabine.]
[M01CB01, gold sodium thiomalate, Capecitabine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Capecitabine may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Capecitabine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C08CA02, felodipine, The metabolism of Capecitabine can be decreased when combined with Felodipine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Capecitabine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Capecitabine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Capecitabine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[G04BD02, flavoxate, Capecitabine may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The metabolism of Capecitabine can be decreased when combined with Flecainide.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Capecitabine can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Flucytosine is combined with Capecitabine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Capecitabine.]
[V03AB25, flumazenil, Capecitabine may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Capecitabine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Capecitabine.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluocinonide is combined with Capecitabine.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Capecitabine can be decreased when combined with Ethanol.]
[L01BC09, floxuridine, The metabolism of Capecitabine can be decreased when combined with Floxuridine.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Capecitabine.]
[L01BC02, fluorouracil, The metabolism of Capecitabine can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The metabolism of Capecitabine can be decreased when combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of myelosuppression can be increased when Flupentixol is combined with Capecitabine.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Capecitabine.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[V04CX02, folic acid, The risk or severity of adverse effects can be increased when Folic acid is combined with Capecitabine.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01BC03, tegafur, Capecitabine may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C10AB04, gemfibrozil, The metabolism of Capecitabine can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Capecitabine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Dasatinib.]
[J05AG04, etravirine, The metabolism of Capecitabine can be decreased when combined with Etravirine.]
[A10BB01, glyburide, The metabolism of Capecitabine can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Capecitabine.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Capecitabine.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Capecitabine.]
[L01EX02, sorafenib, The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Capecitabine.]
[M01CB04, aurothioglucose, Capecitabine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Capecitabine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Capecitabine.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01EX01, guanethidine, Capecitabine may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N05AD01, haloperidol, The metabolism of Haloperidol can be decreased when combined with Capecitabine.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Capecitabine.]
[N05AH04, quetiapine, Capecitabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Capecitabine may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The risk or severity of adverse effects can be increased when Irinotecan is combined with Capecitabine.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Capecitabine.]
[C09CA01, losartan, The metabolism of Losartan can be decreased when combined with Capecitabine.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Heparin is combined with Capecitabine.]
[G03DC01, allylestrenol, Capecitabine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Capecitabine.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Capecitabine.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Capecitabine.]
[M02AA26, nimesulide, The risk or severity of bleeding can be increased when Nimesulide is combined with Capecitabine.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C02DB02, hydralazine, Capecitabine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[S02BA01, hydrocortisone, The metabolism of Capecitabine can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Capecitabine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[G04BD06, propiverine, Capecitabine may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Hydroxychloroquine.]
[B05AA07, hetastarch, Capecitabine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Capecitabine.]
[J04AB04, rifabutin, The metabolism of Capecitabine can be increased when combined with Rifabutin.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Capecitabine.]
[B05XA08, sodium acetate, Capecitabine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Capecitabine.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Capecitabine is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ifosfamide.]
[N06AA02, imipramine, Imipramine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Capecitabine is combined with Paclitaxel.]
[L01CD03, paclitaxel poliglumex, The risk or severity of cardiotoxicity can be increased when Capecitabine is combined with Paclitaxel poliglumex.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Capecitabine is combined with Tixocortol.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Topotecan is combined with Capecitabine.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Capecitabine.]
[A11HA07, inositol, Capecitabine may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Capecitabine.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Capecitabine.]
[N06AX17, milnacipran, Capecitabine may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[J05AB15, brivudine, The risk or severity of adverse effects can be increased when Brivudine is combined with Capecitabine.]
[S01XA28, varenicline, Capecitabine may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Articaine.]
[A10BH01, sitagliptin, Capecitabine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Capecitabine.]
[C10AA06, cerivastatin, The metabolism of Capecitabine can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of bleeding can be increased when Anagrelide is combined with Capecitabine.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Capecitabine.]
[V03AB01, ipecac, Capecitabine may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AF05, iproniazid, The metabolism of Capecitabine can be decreased when combined with Iproniazid.]
[P01AX06, atovaquone, The metabolism of Capecitabine can be decreased when combined with Atovaquone.]
[J04AC01, isoniazid, The metabolism of Capecitabine can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Capecitabine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Capecitabine.]
[S01AA24, kanamycin, Capecitabine may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Capecitabine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Capecitabine.]
[C02KD01, ketanserin, The risk or severity of bleeding can be increased when Ketanserin is combined with Capecitabine.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Capecitabine.]
[N05AH03, olanzapine, The metabolism of Capecitabine can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AA24, abatacept, The metabolism of Capecitabine can be increased when combined with Abatacept.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Capecitabine.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Capecitabine.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Lidocaine.]
[S01AA21, amikacin, Capecitabine may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Capecitabine can be decreased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Lomustine.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Capecitabine can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Capecitabine.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Capecitabine is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Capecitabine may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Capecitabine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Capecitabine is combined with Pralatrexate.]
[L01EA03, nilotinib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Capecitabine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C01AA08, medigoxin, Metildigoxin may decrease the cardiotoxic activities of Capecitabine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Capecitabine.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Capecitabine.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Capecitabine.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Melphalan is combined with Capecitabine.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Capecitabine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Mepivacaine.]
[G04BX16, tiopronin, Capecitabine may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Capecitabine may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Capecitabine.]
[N06BA03, methamphetamine, Capecitabine may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Capecitabine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Capecitabine.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Methotrexate is combined with Capecitabine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Capecitabine.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[V04CG05, methylene blue, The metabolism of Capecitabine can be decreased when combined with Methylene blue.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Capecitabine.]
[G03EK01, methyltestosterone, Capecitabine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, Capecitabine may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[P01AB01, metronidazole, The serum concentration of the active metabolites of Capecitabine can be increased when Capecitabine is used in combination with Metronidazole.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S02AA13, miconazole, The metabolism of Capecitabine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Capecitabine.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Capecitabine.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[G03XB01, mifepristone, The metabolism of Capecitabine can be decreased when combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Capecitabine.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C09CA03, valsartan, The metabolism of Capecitabine can be decreased when combined with Valsartan.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Capecitabine.]
[C01BD01, amiodarone, The metabolism of Capecitabine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Capecitabine.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Capecitabine can be increased when combined with Certolizumab pegol.]
[G04BA01, ammonium chloride, Capecitabine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Ofatumumab.]
[L01EX03, pazopanib, The risk or severity of adverse effects can be increased when Capecitabine is combined with Pazopanib.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Capecitabine.]
[P01BA06, amodiaquine, The metabolism of Capecitabine can be decreased when combined with Amodiaquine.]
[N03AB05, fosphenytoin, The serum concentration of Fosphenytoin can be increased when it is combined with Capecitabine.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Capecitabine.]
[C07AA12, nadolol, Capecitabine may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[V03AB15, naloxone, Capecitabine may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[L04AC03, anakinra, The metabolism of Capecitabine can be increased when combined with Anakinra.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Capecitabine.]
[A10BG01, troglitazone, The metabolism of Capecitabine can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Capecitabine.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Capecitabine.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Capecitabine is combined with Docetaxel.]
[S03AA01, neomycin, Capecitabine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Capecitabine.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L03AX16, plerixafor, Capecitabine may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Capecitabine may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Capecitabine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C01CE01, inamrinone, Capecitabine may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Capecitabine.]
[C08CA04, nicardipine, The metabolism of Capecitabine can be decreased when combined with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Capecitabine.]
[C08CA05, nifedipine, Capecitabine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C02KX01, bosentan, The metabolism of Capecitabine can be increased when combined with Bosentan.]
[R05DA07, noscapine, The metabolism of Capecitabine can be decreased when combined with Noscapine.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Capecitabine.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Capecitabine.]
[L04AC04, rilonacept, The metabolism of Capecitabine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Capecitabine.]
[N02AA02, opium, Capecitabine may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Capecitabine.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Capecitabine.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C01AC01, ouabain, Ouabain may decrease the cardiotoxic activities of Capecitabine.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A14AA08, oxandrolone, The metabolism of Capecitabine can be decreased when combined with Oxandrolone.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Capecitabine.]
[J04AB30, capreomycin, Capecitabine may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Capecitabine is combined with Paramethasone.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[G04BD11, fesoterodine, Capecitabine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Capecitabine may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Penicillamine is combined with Capecitabine.]
[J01CE09, penicillin G procaine, Capecitabine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Capecitabine.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Capecitabine.]
[N05CA01, pentobarbital, Pentobarbital may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Capecitabine.]
[C04AD03, pentoxifylline, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Capecitabine.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Capecitabine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Capecitabine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Capecitabine is combined with Phenindione.]
[N03AA02, phenobarbital, The metabolism of Capecitabine can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Capecitabine.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[M02AA01, phenylbutazone, The metabolism of Capecitabine can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be increased when it is combined with Capecitabine.]
[L04AB06, golimumab, The metabolism of Capecitabine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Capecitabine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N06BX03, piracetam, Capecitabine may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, The metabolism of Piroxicam can be decreased when combined with Capecitabine.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J05AG02, delavirdine, The metabolism of Capecitabine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Capecitabine.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Capecitabine.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Capecitabine.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be decreased when combined with Capecitabine.]
[L02BG03, anastrozole, The risk or severity of cardiotoxicity can be increased when Capecitabine is combined with Anastrozole.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Capecitabine.]
[L04AC08, canakinumab, The metabolism of Capecitabine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The metabolism of Capecitabine can be increased when combined with Ritonavir.]
[A10BH03, saxagliptin, Capecitabine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Capecitabine.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Prednisolone is combined with Capecitabine.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Capecitabine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Prilocaine.]
[N03AA03, primidone, The metabolism of Capecitabine can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Capecitabine can be decreased when combined with Probenecid.]
[C01BA02, procainamide, Capecitabine may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Capecitabine can be decreased when combined with Fenofibrate.]
[G03DA04, progesterone, The metabolism of Capecitabine can be decreased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Capecitabine.]
[R06AD02, promethazine, The metabolism of Capecitabine can be decreased when combined with Promethazine.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Capecitabine.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Capecitabine.]
[C01AB01, proscillaridin, Proscillaridin may decrease the cardiotoxic activities of Capecitabine.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[B01AC09, epoprostenol, The risk or severity of bleeding can be increased when Epoprostenol is combined with Capecitabine.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Capecitabine.]
[N07XX07, dalfampridine, Capecitabine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Capecitabine may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Capecitabine.]
[C01BA01, quinidine, The metabolism of Capecitabine can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Quinine can be decreased when combined with Capecitabine.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Capecitabine.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Capecitabine.]
[N05CA06, secobarbital, The metabolism of Capecitabine can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Capecitabine.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Capecitabine is combined with Obinutuzumab.]
[J01GB08, sisomicin, Capecitabine may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Capecitabine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Capecitabine.]
[V04CC01, sorbitol, Capecitabine may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[L01CD04, cabazitaxel, The risk or severity of adverse effects can be increased when Capecitabine is combined with Cabazitaxel.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Capecitabine.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Trastuzumab emtansine.]
[V09AB03, ioflupane I-123, Capecitabine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Capecitabine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Capecitabine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[N03AG01, valproic acid, The metabolism of Capecitabine can be decreased when combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Capecitabine is combined with Hydrocortisone butyrate.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
